Articles Vol. 67 No. 3 31/03/2026

NEUROGENETICS OVERVIEW OF MENTAL HEALTH DISORDERS: SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION

Nguyen Thi Hong Xuan1,2
1 Psychology Department, Faculty of Social Sciences and Public Relations Ho Chi Minh City University of Technology
2 Ngành Tâm lý học, Khoa khoa học xã hội và quan hệ công chúng Đại học Công nghệ TP.HCM
DOI: 10.52163/yhc.v67i3.4634
53 Views
16 Downloads
Keywords
Neurogenetics; mental health disorders; schizophrenia; bipolar disorder; depression; movement-environment interactions; personalized medicine.
Abstract

ABSTRACT

Objective:

To provide a structured narrative review of updated evidence on the neurogenetics of common mental health disorders, specifically schizophrenia, bipolar disorder, and depression.

Method:

A structured narrative review was conducted by identifying high-impact studies from 2021-2025 via PubMed and Google Scholar. Ten selected articles focusing on genome-wide association studies (GWAS), polygenic risk scores (PRS), and gene-environment interactions were synthesized to come to conclusions on the neurogenetic architecture of these disorders.

Result:

Mental health disorders, particularly the three studied, are formed by a complex polygenic architecture. Genetic variations contribute to biological vulnerability, which, when interacting with adverse environmental factors and psychological resilience, can trigger or exacerbate symptoms through changes in neural structure and function.

Conclusion:

Understanding of neurogenetics not only clarifies aspects of disease causation but also supports mental health’s early diagnosis and personalized medicine.

References
[1]
World Health Organization. Mental disorders [Internet]. Geneva: WHO; 2025 [cited 2026 Mar 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/mental-disorders Google Scholar
[2]
Kato H, Kimura H, Kushima I, Takahashi N, Aleksic B, Ozaki N. The genetic architecture of schizophrenia: review of large-scale genetic studies. J Hum Genet. 2023;68(3):175-182. https://doi.org/10.1038/s10038-022-01059-4 Google Scholar
[3]
Peedicayil J. Genome-Environment Interactions and Psychiatric Disorders. Biomedicines. 2023;11(4):1209. https://doi.org/10.3390/biomedicines11041209 Google Scholar
[4]
Forero DA. Genomics of psychiatric disorders: Regional challenges and opportunities. Biomedica. 2023;43(1):5-7. https://doi.org/10.7705/biomedica.6996 Google Scholar
[5]
Tian H, Hu Z, Xu J, Wang C. The molecular pathophysiology of depression and the new therapeutics. MedComm. 2022;3(3):e156. https://doi.org/10.1002/mco2.156 Google Scholar
[6]
Wahbeh MH, Avramopoulos D. Gene-Environment Interactions in Schizophrenia: A Literature Review. Genes (Basel). 2021;12(12):1850. https://doi.org/10.3390/genes12121850 Google Scholar
[7]
Owen MJ, Legge SE, Rees E, Walters JTR, O'Donovan MC. Genomic findings in schizophrenia and their implications. Mol Psychiatry. 2023;28(9):3638-3647. https://doi.org/10.1038/s41380-023-02293-8 Google Scholar
[8]
Robinson N, Bergen SE. Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions. Front Genet. 2021;12:686666. https://doi.org/10.3389/fgene.2021.686666 Google Scholar
[9]
Remes O, Mendes JF, Templeton P. Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature. Brain Sci. 2021;11(12):1633. https://doi.org/10.3390/brainsci11121633 Google Scholar
[10]
Alshaya DS. Genetic and epigenetic factors associated with depression: An updated overview. Saudi J Biol Sci. 2022;29(8):103311. https://doi.org/10.1016/j.sjbs.2022.103311 Google Scholar